Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Rheumatoid Arthritis

NCT01059448 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01059448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01059448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Rheumatoid Arthritis
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Terminated
Start date
June 3, 2010
Completion date
April 5, 2011
Enrollment
211 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis